🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Lee Ainslie’s BIIB Holdings & Trades

First Buy
Q1 2016
Duration Held
19 Quarters
Largest Add
Q1 2016
+9,370 Shares
Current Position
2,279 Shares
$514,781 Value

Lee Ainslie's BIIB Position Overview

Lee Ainslie (via Maverick Capital LTD) currently holds 2,279 shares of Biogen Inc. (BIIB) worth $514,781, representing 0.00% of the portfolio. First purchased in 2016-Q1, this medium-term investment has been held for 19 quarters.

Based on 13F filings, Lee Ainslie has maintained a strategic position in BIIB, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2017, adding 5,620 shares. Largest reduction occurred in Q3 2017, reducing 15,230 shares.

Analysis based on 13F filings available since 2013 Q2

Lee Ainslie's Biogen (BIIB) Holding Value Over Time

Track share changes against reported price movement

Quarterly Biogen (BIIB) Trades by Lee Ainslie

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +2,279 New Buy 2,279 $225.88
Q1 2024 -1,600 Sold Out 0 $0.00
Q4 2023 +1,600 New Buy 1,600 $258.77
Q3 2023 -983 Sold Out 0 $0.00
Q2 2023 +983 New Buy 983 $284.85
Q4 2021 -3,112 Sold Out 0 $0.00
Q3 2021 +3,112 New Buy 3,112 $283.10
Q4 2020 -1,436 Sold Out 0 $0.00
Q3 2020 -3,065 Reduce 68.10% 1,436 $283.43
Q2 2020 +4,501 New Buy 4,501 $267.50
Q4 2019 -4,919 Sold Out 0 $0.00
Q3 2019 +4,919 New Buy 4,919 $232.77
Q3 2017 -15,230 Sold Out 0 $0.00
Q2 2017 +5,620 Add 58.48% 15,230 $271.37
Q1 2017 -1,270 Reduce 11.67% 9,610 $273.47
Q4 2016 +500 Add 4.82% 10,880 $283.55
Q3 2016 -630 Reduce 5.72% 10,380 $313.01
Q2 2016 +1,640 Add 17.50% 11,010 $241.78
Q1 2016 +9,370 New Buy 9,370 $260.30

Lee Ainslie's Biogen Investment FAQs

Lee Ainslie first purchased Biogen Inc. (BIIB) in Q1 2016, acquiring 9,370 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Lee Ainslie has held Biogen Inc. (BIIB) for 19 quarters since Q1 2016.

Lee Ainslie's largest addition to Biogen Inc. (BIIB) was in Q1 2016, adding 9,370 shares worth $2.44 M.

According to the latest 13F filing for Q3 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 2,279 shares of Biogen Inc. (BIIB), valued at approximately $514,781.

As of the Q3 2026 filing, Biogen Inc. (BIIB) represents approximately 0.00% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.

Lee Ainslie's peak holding in Biogen Inc. (BIIB) was 15,230 shares, as reported at the end of Q2 2017.